(Q40594427)

21 September 2017

Albumin is a necessary stabilizer of TBE-vaccine to avoid fever in children after vaccination (English)

1 reference

21 September 2017

Marth E

1

1 reference

PubMed ID

11672919

21 September 2017

Kleinhappl B

series ordinal

2

1 reference

PubMed ID

11672919

21 September 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

21 September 2017

1 reference

21 September 2017

20

1 reference

21 September 2017

3-4

1 reference

21 September 2017

532-537

1 reference

A randomized phase II study of a new tick-borne encephalitis vaccine using three different doses and two immunization regimens

21 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900329-2

7 January 2021

A new vaccine against tick-borne encephalitis: initial trial in man including a dose-response study

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900329-2

7 January 2021

Humoral immunity against tick-borne encephalitis virus following manifest disease and active immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900329-2

7 January 2021

A topological and functional model of epitopes on the structural glycoprotein of tick-borne encephalitis virus defined by monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900329-2

7 January 2021

Immunogenicity and reactogenicity of a highly purified vaccine against tick‐borne encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900329-2

7 January 2021

Preparation of a highly purified vaccine against tick-borne encephalitis by continuous flow zonal ultracentrifugation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900329-2

7 January 2021

Can we reduce the dose of a vaccine?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900329-2

7 January 2021

Tick-borne encephalitis: development of a paediatric vaccine. A controlled, randomized, double-blind and multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900329-2

7 January 2021

Molecular structure of staphylococcus and streptococcus superantigens.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900329-2

7 January 2021

Superantigens: mechanism of T-cell stimulation and role in immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900329-2

7 January 2021

Pathogenesis of the toxic shock syndrome: T cell mediated lethal shock caused by the superantigen TSST-1

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900329-2

7 January 2021

Mediators in the pathogenesis of toxic shock syndrome: overview.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900329-2

7 January 2021

Tumor necrosis factor: a pleiotropic cytokine and therapeutic target

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900329-2

7 January 2021

Differential regulation of tumour necrosis factor-alpha mRNA degradation in macrophages by interleukin-4 and interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900329-2

7 January 2021

Biochemical and Biological Characterization of Neutrophil Chemotactic Protein, a Novel Rabbit CXC Chemokine from Alveolar Macrophages†

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900329-2

7 January 2021

Proinflammatory cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900329-2

7 January 2021

10.1016/S0264-410X(01)00329-2

Identifiers

DOI

1 reference

21 September 2017

1 reference

PubMed ID

11672919